Breadcrumb

CHAL  |  Cardiovascular Health across the Lifespan Program

Our Researchers

The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.

Filters icon icon

Displaying 21 result(s).

Amal Bessissow, MD, M.Sc., FRCPC

perioperative medicine

cardiovascular outcomes

six-minute walk test

CORE

Dominic Chalut, MD

asthma

toxicology

quality assurance

trauma

pediatric emergency medicine

Robert Côté, MD

stroke

stroke prevention

acute management

clinical research

Vidal Essebag, MD, PhD

Epidemiology

statistical analysis

methodology

database analysis

data management

Matthias Friedrich, MD, FESC, FACC

Cardiovascular magnetic resonance

myocardial ischemia

coronary heart disease

acute myocardial infarction

myocarditis

CTB

Nadia Giannetti, MD

heart attack

défaillance cardiaque

heart transplantation

greffe cardiaque

cardiomyopathy

Thao Huynh, MD, PhD

cardiovascular

sex and gender

ethnicity

knowledge translation

guidelines

Kevin Lachapelle, MD

Marrow stromal cells

angiogenesis

revascularization

Ilka Lowensteyn, PhD

Cardiac rehabilitation

exercise physiology

kinesiology

prevention

wellness

Sheldon Magder, MD

Vascular biology

endothelial function

nitric oxide

estrogen

oxygen radicals

Nicolo Piazza, MD, PhD, FRCO(C), FESC

Aortic Valve

mitral Valve

transcatheter valves

transcatheter aortic valve implantation

transcatheter aortic valve replacement

Explore what the CHAL Program has to offer